Jonathan T. Edelson
Fondateur chez Anterios, Inc.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Albert F. Hummel | M | 78 |
Anterios, Inc.
 Anterios, Inc. Pharmaceuticals: MajorHealth Technology Anterios, Inc. develops botulinum-based products for medical dermatology and aesthetic medicine. Its products include ANT-1207 which treats hyperhidrosis, and AI-09 which is a novel injectable formulation for therapeutic indications. The company was founded by John Edelson and is headquartered in Madison, NJ.
Eirion Therapeutics, Inc.
 Eirion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Eirion Therapeutics, Inc. is a clinical stage biopharmaceutical company that is developing prescription products for aesthetic dermatology. The company is based in Woburn, MA. The company has a pipeline of products that focus on treatments for wrinkles, primary axillary hyperhidrosis, androgenic alopecia, and hair greying. Eirion plans to pursue additional indications that address other major unmet clinical needs for physicians and their patients. The company was founded in 2016. Jonathan T. Edelson has been the CEO of the company since 2016. | 8 ans |
| Barry Kurokawa | M | 68 |
Anterios, Inc.
Anterios, Inc. Pharmaceuticals: MajorHealth Technology Anterios, Inc. develops botulinum-based products for medical dermatology and aesthetic medicine. Its products include ANT-1207 which treats hyperhidrosis, and AI-09 which is a novel injectable formulation for therapeutic indications. The company was founded by John Edelson and is headquartered in Madison, NJ.
Eirion Therapeutics, Inc.
Eirion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Eirion Therapeutics, Inc. is a clinical stage biopharmaceutical company that is developing prescription products for aesthetic dermatology. The company is based in Woburn, MA. The company has a pipeline of products that focus on treatments for wrinkles, primary axillary hyperhidrosis, androgenic alopecia, and hair greying. Eirion plans to pursue additional indications that address other major unmet clinical needs for physicians and their patients. The company was founded in 2016. Jonathan T. Edelson has been the CEO of the company since 2016. | 9 ans |
| Steve Hochberg | M | 62 |
ABV LLC
 ABV LLC Investment ManagersFinance ABV LLC(Ascent Biomedical) is a venture capital firm founded in 2004 by Steven I Hochberg, Geoffrey W Smith and Steve Hochberg. The firm is headquartered in New York. | 20 ans |
| Carter Meyer | M | 55 |
Anterios, Inc.
Anterios, Inc. Pharmaceuticals: MajorHealth Technology Anterios, Inc. develops botulinum-based products for medical dermatology and aesthetic medicine. Its products include ANT-1207 which treats hyperhidrosis, and AI-09 which is a novel injectable formulation for therapeutic indications. The company was founded by John Edelson and is headquartered in Madison, NJ.
Eirion Therapeutics, Inc.
Eirion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Eirion Therapeutics, Inc. is a clinical stage biopharmaceutical company that is developing prescription products for aesthetic dermatology. The company is based in Woburn, MA. The company has a pipeline of products that focus on treatments for wrinkles, primary axillary hyperhidrosis, androgenic alopecia, and hair greying. Eirion plans to pursue additional indications that address other major unmet clinical needs for physicians and their patients. The company was founded in 2016. Jonathan T. Edelson has been the CEO of the company since 2016. | 8 ans |
| Geoffrey Smith | M | - |
ABV LLC
ABV LLC Investment ManagersFinance ABV LLC(Ascent Biomedical) is a venture capital firm founded in 2004 by Steven I Hochberg, Geoffrey W Smith and Steve Hochberg. The firm is headquartered in New York. | 20 ans |
| Jeffrey M. Sauerhoff | M | 75 |
ABV LLC
ABV LLC Investment ManagersFinance ABV LLC(Ascent Biomedical) is a venture capital firm founded in 2004 by Steven I Hochberg, Geoffrey W Smith and Steve Hochberg. The firm is headquartered in New York. | - |
| Ambrose Bailey | M | 60 |
Anterios, Inc.
Anterios, Inc. Pharmaceuticals: MajorHealth Technology Anterios, Inc. develops botulinum-based products for medical dermatology and aesthetic medicine. Its products include ANT-1207 which treats hyperhidrosis, and AI-09 which is a novel injectable formulation for therapeutic indications. The company was founded by John Edelson and is headquartered in Madison, NJ. | - |
| Kevin Finney | M | - |
Eirion Therapeutics, Inc.
Eirion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Eirion Therapeutics, Inc. is a clinical stage biopharmaceutical company that is developing prescription products for aesthetic dermatology. The company is based in Woburn, MA. The company has a pipeline of products that focus on treatments for wrinkles, primary axillary hyperhidrosis, androgenic alopecia, and hair greying. Eirion plans to pursue additional indications that address other major unmet clinical needs for physicians and their patients. The company was founded in 2016. Jonathan T. Edelson has been the CEO of the company since 2016. | 8 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Fabian Tenenbaum | M | 50 |
Anterios, Inc.
Anterios, Inc. Pharmaceuticals: MajorHealth Technology Anterios, Inc. develops botulinum-based products for medical dermatology and aesthetic medicine. Its products include ANT-1207 which treats hyperhidrosis, and AI-09 which is a novel injectable formulation for therapeutic indications. The company was founded by John Edelson and is headquartered in Madison, NJ. | 2 ans |
| Klaus P. J. Theobald | M | 68 |
Anterios, Inc.
Anterios, Inc. Pharmaceuticals: MajorHealth Technology Anterios, Inc. develops botulinum-based products for medical dermatology and aesthetic medicine. Its products include ANT-1207 which treats hyperhidrosis, and AI-09 which is a novel injectable formulation for therapeutic indications. The company was founded by John Edelson and is headquartered in Madison, NJ. | 7 ans |
| Mary Senica | F | 63 |
Anterios, Inc.
Anterios, Inc. Pharmaceuticals: MajorHealth Technology Anterios, Inc. develops botulinum-based products for medical dermatology and aesthetic medicine. Its products include ANT-1207 which treats hyperhidrosis, and AI-09 which is a novel injectable formulation for therapeutic indications. The company was founded by John Edelson and is headquartered in Madison, NJ. | 5 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 11 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Jonathan T. Edelson
- Réseau Personnel
